Working in line with the latest World Health Organization recommendations for DR-TB, our teams began providing drugs and technical advice to support the treatment of patients with the most severe forms of TB in the Arkhangelsk region in January.
By the end of the year, we had supported the treatment of 23 patients. In partnership with Arkhangelsk Regional Ministry of Health, Northern State Medical University, and Arkhangelsk Clinical TB Dispensary, we are building on existing expertise and working together to implement novel all-oral short-course regimens.
The aim of the collaboration is to provide evidence for future developments in TB policy in Russia and increase the availability of more effective models of treatment. Our teams have been working in Russia since the early 1990s, running programs in Moscow, Saint Petersburg, Kemerovo region, Chechnya, Ingushetia and Dagestan.
No. staff in 2019: 30 | Expenditure in 2019: €1.2 million | Year MSF first worked in the country: 1992
- Try a different country, year, format, or topic.
- Clear one or more filters